Alzheimer's Disease – The Evaluation & Management of Dementia 2013

Apollo Managed Care, Inc., January 2013, Pages: 70

Diagnosis of Alzheimer's and other dementias, non-pharmaceutical and pharmaceutical management of this common cluster of disabling disorders. References. Web links/other resources

Preface

Introduction to this volume

References list for the introduction

Evidence-based Medicine web sites

Behavioral Health Care – Access to care

Introduction and differential diagnosis

Mild Cognitive Impairment (MCI)

Contributing factors, potential

Initial assessment

Reversible causes of dementia

Diagnostic criteria for dementia and Alzheimer's disease

Brain scans (CT, MRI, PET) for the prediction and evaluation of dementia

CSF for Alzheimer Disease

Urinary tests for Alzheimer's Disease

Tau, BA-42 and Apolipoprotein E Tests for Alzheimer's Disease

Videopupillography tropicamide drop test

Screening examinations/tests for dementia

Clinical course and findings during progressive stages of Alzheimer's disease

Financial competence

Post-assessment care

AD in adults with mental retardation

Long term care

Reporting requirements

Decreasing the risk of developing Alzheimer's disease – medications, nutrition

Alcohol

Exercise as a protective factor

Diet linked to good cognitive performance in old age

Fats in the diet – relationship to AD

Dietary niacin may be protective

Treatment

Nonpharmacologic therapy

Pharmacologic therapy

- Anti-psychotic drug therapy
- Estrogen therapy

Caring for the caregiver

Long-term nursing home care/Hospice care

Palliative Care

Ethical treatment considerations

Feeding tubes (added 10-03)

Algorithm

Genetic predisposition to dementia

Depression and cognitive function

References/Recommended Reading

Resources

National associations/organizations – Alzheimer's disease

Alzheimer's Disease Web Site Links

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Neuroprotection - Drugs, Markets and Companies
• Alzheimer's Disease (Event Driven)
• Biomarkers - Technologies, Markets and Companies
• Mild Cognitive Impairment and Early Alzheimer's Disease. Detection and Diagnosis
• Medical Review Criteria Guidelines for Managing Care (12th edition, 2013)
• The Handbook of Alzheimer's Disease and Other Dementias. Blackwell Handbooks of Behavioral Neuroscience
• Epidemiology: Alzheimer's Disease - Differential aging between genders will dramatically impact prevalent cases
• Global Alzheimer Prevalence and Drugs Demand
• Pipeline and Commercial Insight: Alzheimer's Disease - Market cautiously awaits the first generation of disease-modifying therapies
• Prescribing Influences: Alzheimer's Disease - Alleviating symptoms remains the goal for prescribers